These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15998341)

  • 1. Gene expression and matrix turnover in overused and damaged tendons.
    Riley GP
    Scand J Med Sci Sports; 2005 Aug; 15(4):241-51. PubMed ID: 15998341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic tendon pathology: molecular basis and therapeutic implications.
    Riley G
    Expert Rev Mol Med; 2005 Mar; 7(5):1-25. PubMed ID: 15796783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tendinopathy--from basic science to treatment.
    Riley G
    Nat Clin Pract Rheumatol; 2008 Feb; 4(2):82-9. PubMed ID: 18235537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metabolism rate differs in functionally distinct tendons.
    Birch HL; Worboys S; Eissa S; Jackson B; Strassburg S; Clegg PD
    Matrix Biol; 2008 Apr; 27(3):182-9. PubMed ID: 18032005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading.
    Kjaer M
    Physiol Rev; 2004 Apr; 84(2):649-98. PubMed ID: 15044685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achilles tendinosis: changes in biochemical composition and collagen turnover rate.
    de Mos M; van El B; DeGroot J; Jahr H; van Schie HT; van Arkel ER; Tol H; Heijboer R; van Osch GJ; Verhaar JA
    Am J Sports Med; 2007 Sep; 35(9):1549-56. PubMed ID: 17478653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early events of overused supraspinatus tendons involve matrix metalloproteinases and EMMPRIN/CD147 in the absence of inflammation.
    Attia M; Huet E; Gossard C; Menashi S; Tassoni MC; Martelly I
    Am J Sports Med; 2013 Apr; 41(4):908-17. PubMed ID: 23404084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of vasculature and angiogenesis for the pathogenesis of degenerative tendons disease.
    Pufe T; Petersen WJ; Mentlein R; Tillmann BN
    Scand J Med Sci Sports; 2005 Aug; 15(4):211-22. PubMed ID: 15998338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tendon degeneration is not mediated by regulation of Toll-like receptors 2 and 4 in human tenocytes.
    de Mos M; Joosten LA; Oppers-Walgreen B; van Schie JT; Jahr H; van Osch GJ; Verhaar JA
    J Orthop Res; 2009 Aug; 27(8):1043-7. PubMed ID: 19148938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achilles tendon disorders: etiology and epidemiology.
    Järvinen TA; Kannus P; Maffulli N; Khan KM
    Foot Ankle Clin; 2005 Jun; 10(2):255-66. PubMed ID: 15922917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of aggrecan and biglycan mRNA in Achilles tendinopathy.
    Corps AN; Robinson AH; Movin T; Costa ML; Hazleman BL; Riley GP
    Rheumatology (Oxford); 2006 Mar; 45(3):291-4. PubMed ID: 16219640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging enhances a mechanically-induced reduction in tendon strength by an active process involving matrix metalloproteinase activity.
    Dudhia J; Scott CM; Draper ER; Heinegård D; Pitsillides AA; Smith RK
    Aging Cell; 2007 Aug; 6(4):547-56. PubMed ID: 17578513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in mechanical loading lead to tendonspecific alterations in MMP and TIMP expression: influence of stress deprivation and intermittent cyclic hydrostatic compression on rat supraspinatus and Achilles tendons.
    Thornton GM; Shao X; Chung M; Sciore P; Boorman RS; Hart DA; Lo IK
    Br J Sports Med; 2010 Aug; 44(10):698-703. PubMed ID: 18801769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Versican splice variant messenger RNA expression in normal human Achilles tendon and tendinopathies.
    Corps AN; Robinson AH; Movin T; Costa ML; Ireland DC; Hazleman BL; Riley GP
    Rheumatology (Oxford); 2004 Aug; 43(8):969-72. PubMed ID: 15138331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of proteoglycans in tendon.
    Rees SG; Dent CM; Caterson B
    Scand J Med Sci Sports; 2009 Aug; 19(4):470-8. PubMed ID: 19422635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic activity and collagen turnover in human tendon in response to physical activity.
    Kjaer M; Langberg H; Miller BF; Boushel R; Crameri R; Koskinen S; Heinemeier K; Olesen JL; Døssing S; Hansen M; Pedersen SG; Rennie MJ; Magnusson P
    J Musculoskelet Neuronal Interact; 2005 Mar; 5(1):41-52. PubMed ID: 15788870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of aggrecan and ADAMTS expression in ovine tendinopathy induced by altered strain.
    Smith MM; Sakurai G; Smith SM; Young AA; Melrose J; Stewart CM; Appleyard RC; Peterson JL; Gillies RM; Dart AJ; Sonnabend DH; Little CB
    Arthritis Rheum; 2008 Apr; 58(4):1055-66. PubMed ID: 18383380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular interactions in extracellular matrix of tendon.
    Karousou E; Ronga M; Vigetti D; Barcolli D; Passi A; Maffulli N
    Front Biosci (Elite Ed); 2010 Jan; 2(1):1-12. PubMed ID: 20036847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanobiology of tendon.
    Wang JH
    J Biomech; 2006; 39(9):1563-82. PubMed ID: 16000201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenascin-C and human tendon degeneration.
    Riley GP; Harrall RL; Cawston TE; Hazleman BL; Mackie EJ
    Am J Pathol; 1996 Sep; 149(3):933-43. PubMed ID: 8780397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.